ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023 earnings call.
Stay updated with breaking news from Chris Ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023 earnings call.
Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a paper using a generative artificial intelligence (AI) engine for target discovery from Insilico Medicine (“Insilico”) called PandaOmics to identify new therapeutic targets for glioblastoma multiforme (GBM).
Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China, are three high school students who co-authored a paper utilizing a generative artificial intelligence (AI) engine for target discovery from Insilico Medicine (“Insilico”) known as PandaOmics.
Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a paper using a generative artificial intelligence (AI) engine for target discovery from Insilico Medicine called PandaOmics to identify new therapeutic targets for glioblastoma multiforme. The findings were published on April 26 in the journal Aging.